About
LumiraDx develops rapid, automated diagnostic testing platforms designed for near-patient testing, including COVID-19 antigen detection through microfluidic immunofluorescence assays.
Explore LumiraDx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.